HCPCS Code J3245

Injection, tildrakizumab, 1 mg
Code effective Jan 01, 2019

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J3245 is a valid 2026 HCPCS code meaning Injection, tildrakizumab, 1 mg or (Inj., tildrakizumab, 1 mg) for short. HCPCS J3245 has been effective since 01/01/2019 and applies to Medical care.

HCPCS Code Details - J3245

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J3245
Description

Long description:
Injection, tildrakizumab, 1 mg

Short description:
Inj., tildrakizumab, 1 mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2019
Date added Added Jan 01, 2019

See also

  • HCPCS J3244 · Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg

  • HCPCS J3246 · Injection, tirofiban hcl, 0.25 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.